Infarction Therapy
New infarction therapy study findings have been reported by scientists at Seoul National University, Department of Epidemiology
Published in Blood Weekly, March 4th, 2010
Data detailed in 'Reasonable duration of Clopidogrel use after drug-eluting stent implantation in Korean patients' have been presented. According to recent research from Seoul, Korea, "Current guidelines recommend that clopidogrel be given to patients for 12 months after drug-eluting stent (DES) implantation. However, the evidence is insufficient to support the benefit of long-term clopidogrel therapy, especially in Asian patients."
"The aim of this study was to evaluate whether different durations of clopidogrel use might influence long-term outcomes after DES implantation. A total of 844 patients from 4 medical centers in Korea who had undergone successful DES...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2010-03-04)
More Articles from Blood Weekly
- Broad Institute of Mit and Harvard
Researchers chart genomic map spanning over 2 dozen cancers - JAMA and Archives Journals
Study examines family lineage of King Tut, his possible cause of death - Springer
Month of birth determines who becomes a sports star - University of Wisconsin-Madison
Induced neural stem cells: Not quite ready for prime time - Wiley-Blackwell
New drug for kidney transplant recipients effective in humans - Antibiotics
Data from M.J. Hallam et al provide new insights into antibiotics - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
